ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
O-033 Docetaxel (DOC), cisplatin (CIS) and gemcitabine (GEM) asneoadjuvant treatment in stage IIIAN2 and T4N0-1 non-small cell lung cancer (NSCLC) patients (P). final results of SLCG phase II trial 9901
Lung Cancer
◽
10.1016/s0169-5002(05)80165-5
◽
2005
◽
Vol 49
◽
pp. S14
◽
Cited By ~ 1
Author(s):
P. Garrido
◽
R. Rosell
◽
A. Torres
◽
J. González Larriba
◽
M. Provencio
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Nsclc Patients
Download Full-text
Related Documents
Cited By
References
Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy
10.1158/1538-7445.am2019-ct041
◽
2019
◽
Cited By ~ 1
Author(s):
Peter Ordentlich
◽
Lei Wang
◽
David Tamang
◽
Amy H. Sullivan
◽
Sally E. Church
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Gene Signatures
◽
Nsclc Patients
Download Full-text
Randomised Phase II Trial of Oral Vinorelbine (N) and Cisplatin (P) or Pemetrexed and C (PC) in First Line Advanced Non Squamous (NSCC) Non Small Cell Lung Cancer (NSCLC) Patients (PTS). Navotrial01: Final Results
Annals of Oncology
◽
10.1016/s0923-7534(20)33841-2
◽
2012
◽
Vol 23
◽
pp. ix409
Author(s):
E.H. Tan
◽
L. Havel
◽
M.J. Krzakowski
◽
J. Kollmeier
◽
R. Gervais
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
First Line
◽
Oral Vinorelbine
◽
Nsclc Patients
Download Full-text
Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients
Cancer Gene Therapy
◽
10.1038/cgt.2009.15
◽
2009
◽
Vol 16
(8)
◽
pp. 620-624
◽
Cited By ~ 87
Author(s):
J Nemunaitis
◽
M Nemunaitis
◽
N Senzer
◽
P Snitz
◽
C Bedell
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Tumor Vaccine
◽
Small Cell
◽
Small Cell Lung
◽
Antisense Gene
◽
Nsclc Patients
Download Full-text
Sequential vinorelbine (V) and docetaxel (D) in advanced non-small cell lung cancer (NSCLC) patients age > 70, or with performance status (PS) 2: A SWOG phase II trial (S0027)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7056
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7056-7056
◽
Cited By ~ 5
Author(s):
P. J. Hesketh
◽
K. Chansky
◽
D. H. Lau
◽
J. Crowley
◽
D. R. Gandara
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Performance Status
◽
Small Cell
◽
Small Cell Lung
◽
Nsclc Patients
Download Full-text
P-203 SLCG 9901: phase II trial with cisplatin (cis), gemcitabine (gem) and docetaxel (doc) as neoadjuvant treatment in stage IIIA N2 and T4N0-1 non-small cell lung cancer (NSCLC) patients
Lung Cancer
◽
10.1016/s0169-5002(03)92172-6
◽
2003
◽
Vol 41
◽
pp. S142
Author(s):
Pilar Garrido
◽
Ramón Barceló
◽
Angel Artal
◽
Josefa Terrasa
◽
Bartomeu Massuti
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Neoadjuvant Treatment
◽
Small Cell
◽
Small Cell Lung
◽
Stage Iiia
◽
Nsclc Patients
Download Full-text
Abstract CT041: Identification of gene signatures associated with response in a Phase II trial of entinostat (ENT) plus pembrolizumab (PEMBRO) in non-small cell lung cancer (NSCLC) patients whose disease has progressed on or after anti-PD-(L)1 therapy
10.1158/1538-7445.sabcs18-ct041
◽
2019
◽
Author(s):
Peter Ordentlich
◽
Lei Wang
◽
David Tamang
◽
Amy H. Sullivan
◽
Sally E. Church
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Gene Signatures
◽
Nsclc Patients
Download Full-text
P-533 Single agent weekly paclitaxel chemotherapy in elderly or frailnon-small cell lung cancer (NSCLC) patients: Final results of a phase II trial Spanish Lung Cancer Group (GECP 00/02)
Lung Cancer
◽
10.1016/s0169-5002(05)81026-8
◽
2005
◽
Vol 49
◽
pp. S257-S258
Author(s):
B. Massuti
◽
C. Camps
◽
P. Garrido
◽
N. Viñolas
◽
J. Barcelo
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Single Agent
◽
Small Cell
◽
Small Cell Lung
◽
Cancer Group
◽
Nsclc Patients
Download Full-text
Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: A phase II trial
Lung Cancer
◽
10.1016/j.lungcan.2007.06.003
◽
2007
◽
Vol 58
(2)
◽
pp. 238-245
◽
Cited By ~ 9
Author(s):
C. Pallarés
◽
J. Capdevila
◽
A. Paredes
◽
N. Farré
◽
J.P. Ciria
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Induction Chemotherapy
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Concurrent Radiotherapy
◽
Nsclc Patients
Download Full-text
563. Phase II Trial of Belagenpumatucel-L, a TGF-β2 Antisense Gene Modified Allogeneic Tumor Vaccine in Advanced Non Small Cell Lung Cancer (NSCLC) Patients
Molecular Therapy
◽
10.1016/s1525-0016(16)38921-3
◽
2009
◽
Vol 17
◽
pp. S215
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Tumor Vaccine
◽
Small Cell
◽
Small Cell Lung
◽
Antisense Gene
◽
Nsclc Patients
Download Full-text
P-542 Carboplatin (C) and docetaxel (D) in the second-line treatment of non-small cell lung cancer (NSCLC) patients pretreated with platinum-based regimens. A Phase II trial
Lung Cancer
◽
10.1016/s0169-5002(05)81035-9
◽
2005
◽
Vol 49
◽
pp. S260
Author(s):
G. Numico
◽
L. Buffoni
◽
V. Dongiovanni
◽
M. Schena
◽
C. Fissore
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Second Line
◽
Small Cell Lung
◽
Nsclc Patients
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close